FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386574747> ?p ?o ?g. }

• W4386574747 abstract "The role of local therapies including radical prostatectomy (RP) in prostate cancer (PCa) patients with clinical lymphadenopathies on prostate-specific membrane antigen (PSMA) positron emission tomography/computerized tomography (PET/CT) has scarcely been explored. Limited data are available to identify men who would benefit from RP; on the contrary, those more likely to benefit already have systemic disease.We aimed to assess the predictors of prostate-specific antigen (PSA) persistence in surgically managed PCa patients with lymphadenopathies on a PSMA PET/CT scan by integrating clinical, magnetic resonance imaging (MRI), and PSMA PET/CT parameters.We identified 519 patients treated with RP and extended lymph node dissection, and who received preoperative PSMA PET between 2017 and 2022 in nine referral centers. Among them, we selected 88 patients with nodal uptake at preoperative PSMA PET (miTxN1M0).The outcome was PSA persistence, defined as a PSA value of ≥0.1 ng/ml at the first measurement after surgery. Multivariable logistic regression models tested the predictors of PSA persistence. Covariates consisted of biopsy International Society of Urological Pathology (ISUP) grade group, clinical stage at MRI, and number of positive spots at a PET/CT scan. A regression tree analysis stratified patients into risk groups based on preoperative characteristics.Overall, lymph node invasion (LNI) was detected in 63 patients (72%) and 32 (36%) experienced PSA persistence after RP. At multivariable analyses, having more than two lymph nodal positive findings at PSMA PET, seminal vesicle invasion (SVI) at MRI, and ISUP grade group >3 at biopsy were independent predictors of PSA persistence (all p < 0.05). At the regression tree analysis, patients were stratified in four risk groups according to biopsy ISUP grade, number of positive findings at PET/CT, and clinical stage at MRI. The model depicted good discrimination at internal validation (area under the curve 78%).One out of three miN1M0 patients showed PSA persistence after surgery. Patients with ISUP grade 2-3, as well as patients with organ-confined disease at MRI and a single or two positive nodal findings at PET are those in whom RP may achieve the best oncological outcomes in the context of a multimodal approach. Conversely, patients with a high ISUP grade and extracapsular extension or SVI or more than two spots at PSMA PET should be considered as potentially affected by systemic disease upfront.Our novel and straightforward risk classification integrates currently available preoperative risk tools and should, therefore, assist physician in preoperative counseling of men candidates for radical treatment for prostate cancer with positive lymph node uptake at prostate-specific membrane antigen positron emission tomography." @default.
• W4386574747 created "2023-09-10" @default.
• W4386574747 creator A5002599364 @default.
• W4386574747 creator A5004351505 @default.
• W4386574747 creator A5009200179 @default.
• W4386574747 creator A5009772028 @default.
• W4386574747 creator A5011155325 @default.
• W4386574747 creator A5015978673 @default.
• W4386574747 creator A5018740345 @default.
• W4386574747 creator A5023266580 @default.
• W4386574747 creator A5024210212 @default.
• W4386574747 creator A5025441151 @default.
• W4386574747 creator A5029088271 @default.
• W4386574747 creator A5030336149 @default.
• W4386574747 creator A5031303345 @default.
• W4386574747 creator A5031550729 @default.
• W4386574747 creator A5032156511 @default.
• W4386574747 creator A5046168299 @default.
• W4386574747 creator A5051495145 @default.
• W4386574747 creator A5058667746 @default.
• W4386574747 creator A5061623935 @default.
• W4386574747 creator A5062907808 @default.
• W4386574747 creator A5065018159 @default.
• W4386574747 creator A5070527293 @default.
• W4386574747 creator A5075450801 @default.
• W4386574747 creator A5076729246 @default.
• W4386574747 creator A5077237079 @default.
• W4386574747 creator A5079401169 @default.
• W4386574747 creator A5080019020 @default.
• W4386574747 creator A5083483292 @default.
• W4386574747 creator A5084290670 @default.
• W4386574747 creator A5089516989 @default.
• W4386574747 creator A5089626999 @default.
• W4386574747 date "2023-09-01" @default.
• W4386574747 modified "2023-10-14" @default.
• W4386574747 title "Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters" @default.
• W4386574747 cites W1545430154 @default.
• W4386574747 cites W2126436234 @default.
• W4386574747 cites W2160679358 @default.
• W4386574747 cites W2441140785 @default.
• W4386574747 cites W2765585252 @default.
• W4386574747 cites W2807668963 @default.
• W4386574747 cites W2890338448 @default.
• W4386574747 cites W2896430583 @default.
• W4386574747 cites W2900110039 @default.
• W4386574747 cites W2907010595 @default.
• W4386574747 cites W2913005048 @default.
• W4386574747 cites W2913023403 @default.
• W4386574747 cites W2938747110 @default.
• W4386574747 cites W2963473092 @default.
• W4386574747 cites W2978235428 @default.
• W4386574747 cites W2993683857 @default.
• W4386574747 cites W2994808712 @default.
• W4386574747 cites W3012827461 @default.
• W4386574747 cites W3017283363 @default.
• W4386574747 cites W3036929976 @default.
• W4386574747 cites W3080711163 @default.
• W4386574747 cites W3097158220 @default.
• W4386574747 cites W3129657865 @default.
• W4386574747 cites W3195390581 @default.
• W4386574747 cites W3214208956 @default.
• W4386574747 cites W4286701414 @default.
• W4386574747 cites W4313549642 @default.
• W4386574747 cites W4315754639 @default.
• W4386574747 cites W4327694432 @default.
• W4386574747 cites W4362705037 @default.
• W4386574747 doi "https://doi.org/10.1016/j.euo.2023.08.010" @default.
• W4386574747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37689506" @default.
• W4386574747 hasPublicationYear "2023" @default.
• W4386574747 type Work @default.
• W4386574747 citedByCount "0" @default.
• W4386574747 crossrefType "journal-article" @default.
• W4386574747 hasAuthorship W4386574747A5002599364 @default.
• W4386574747 hasAuthorship W4386574747A5004351505 @default.
• W4386574747 hasAuthorship W4386574747A5009200179 @default.
• W4386574747 hasAuthorship W4386574747A5009772028 @default.
• W4386574747 hasAuthorship W4386574747A5011155325 @default.
• W4386574747 hasAuthorship W4386574747A5015978673 @default.
• W4386574747 hasAuthorship W4386574747A5018740345 @default.
• W4386574747 hasAuthorship W4386574747A5023266580 @default.
• W4386574747 hasAuthorship W4386574747A5024210212 @default.
• W4386574747 hasAuthorship W4386574747A5025441151 @default.
• W4386574747 hasAuthorship W4386574747A5029088271 @default.
• W4386574747 hasAuthorship W4386574747A5030336149 @default.
• W4386574747 hasAuthorship W4386574747A5031303345 @default.
• W4386574747 hasAuthorship W4386574747A5031550729 @default.
• W4386574747 hasAuthorship W4386574747A5032156511 @default.
• W4386574747 hasAuthorship W4386574747A5046168299 @default.
• W4386574747 hasAuthorship W4386574747A5051495145 @default.
• W4386574747 hasAuthorship W4386574747A5058667746 @default.
• W4386574747 hasAuthorship W4386574747A5061623935 @default.
• W4386574747 hasAuthorship W4386574747A5062907808 @default.
• W4386574747 hasAuthorship W4386574747A5065018159 @default.
• W4386574747 hasAuthorship W4386574747A5070527293 @default.
• W4386574747 hasAuthorship W4386574747A5075450801 @default.
• W4386574747 hasAuthorship W4386574747A5076729246 @default.
• W4386574747 hasAuthorship W4386574747A5077237079 @default.
• W4386574747 hasAuthorship W4386574747A5079401169 @default.
• W4386574747 hasAuthorship W4386574747A5080019020 @default.
• W4386574747 hasAuthorship W4386574747A5083483292 @default.

• next